Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Caserotti, M.; Girardi, P.; Rubaltelli, E.; Tasso, A.; Lotto, L.; Gavaruzzi, T. Associations of COVID-19 Risk Perception with Vaccine Hesitancy over Time for Italian Residents. Soc. Sci. Med. 2021, 272, 113688. [Google Scholar] [CrossRef] [PubMed]
- Malik, A.A.; McFadden, S.M.; Elharake, J.; Omer, S.B. Determinants of COVID-19 Vaccine Acceptance in the US. EClinicalMedicine 2020, 26, 100495. [Google Scholar] [CrossRef] [PubMed]
- Al-Qerem, W.A.; Jarab, A.S. COVID-19 Vaccination Acceptance and Its Associated Factors among a Middle Eastern Population. Front. Public Health 2021, 9, 34. [Google Scholar] [CrossRef] [PubMed]
- Accelerating a Safe and Effective COVID-19 Vaccine. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/accelerating-a-safe-and-effective-covid-19-vaccine (accessed on 8 July 2021).
- Puri, N.; Coomes, E.A.; Haghbayan, H.; Gunaratne, K. Social Media and Vaccine Hesitancy: New Updates for the Era of COVID-19 and Globalized Infectious Diseases. Hum. Vaccines Immunother. 2020, 16, 2586–2593. [Google Scholar] [CrossRef] [PubMed]
- Ten Health Issues WHO Will Tackle This Year. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 8 July 2021).
- Dror, A.A.; Eisenbach, N.; Taiber, S.; Morozov, N.G.; Mizrachi, M.; Zigron, A.; Srouji, S.; Sela, E. Vaccine Hesitancy: The Next Challenge in the Fight against COVID-19. Eur. J. Epidemiol. 2020, 35, 775–779. [Google Scholar] [CrossRef] [PubMed]
- Blank, P.R.; Schwenkglenks, M.; Szucs, T.D. Vaccination Coverage Rates in Eleven European Countries during Two Consecutive Influenza Seasons. J. Infect. 2009, 58, 446–458. [Google Scholar] [CrossRef] [PubMed]
- Bossuyt, N.; Damme, P.V.; Grammens, T.; Nadezhda, V.; Filipova, R.; Kaić, B.; Helmuth, I.G.; Trebbien, R.; Valentiner-Branth, P.; Krause, T.G.; et al. Seasonal Influenza Vaccination and Antiviral Use in EU/EEA Member States. European Centre for Disease Prevention and Control. 2018. Available online: https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-vaccination-antiviral-use-eu-eea-member-states (accessed on 30 April 2021).
- Flu Vaccination Coverage, United States, 2019–2020 Influenza Season|FluVaxView|Seasonal Influenza (Flu)|CDC. Available online: https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm (accessed on 30 April 2021).
- Riccio, M.D.; Lina, B.; Caini, S.; Staadegaard, L.; Wiegersma, S.; Kynčl, J.; Combadière, B.; MacIntyre, C.R.; Paget, J. Letter to the Editor: Increase of Influenza Vaccination Coverage Rates during the COVID-19 Pandemic and Implications for the Upcoming Influenza Season in Northern Hemisphere Countries and Australia. Eurosurveillance 2021, 26, 2101143. [Google Scholar] [CrossRef]
- Earnshaw, V.A.; Eaton, L.A.; Kalichman, S.C.; Brousseau, N.M.; Hill, E.C.; Fox, A.B. COVID-19 Conspiracy Beliefs, Health Behaviors, and Policy Support. Transl. Behav. Med. 2020, 10, 850–856. [Google Scholar] [CrossRef] [PubMed]
- Patwardhan, A.; Ohler, A. The Flu Vaccination May Have a Protective Effect on the Course of COVID-19 in the Pediatric Population: When Does Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Meet Influenza? Cureus 2021, 13, e12533. [Google Scholar] [CrossRef] [PubMed]
- Conlon, A.; Ashur, C.; Washer, L.; Eagle, K.A.; Bowman, M.A.H. Impact of the Influenza Vaccine on COVID-19 Infection Rates and Severity. Am. J. Infect. Control. 2021, 49, 694–700. [Google Scholar] [CrossRef] [PubMed]
- Ragni, P.; Marino, M.; Formisano, D.; Bisaccia, E.; Scaltriti, S.; Bedeschi, E.; Grilli, R. Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes. Vaccines 2020, 8, 675. [Google Scholar] [CrossRef] [PubMed]
- Zanettini, C.; Omar, M.; Dinalankara, W.; Imada, E.L.; Colantuoni, E.; Parmigiani, G.; Marchionni, L. Influenza Vaccination and COVID19 Mortality in the USA. medRxiv 2020. [Google Scholar] [CrossRef]
- Wang, R.; Liu, M.; Liu, J. The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies. Vaccines 2021, 9, 529. [Google Scholar] [CrossRef] [PubMed]
- Zaprutko, T.; Kopciuch, D.; Bronisz, M.; Michalak, M.; Kus, K.; Nowakowska, E. Drug Shortages as a Result of Parallel Export in Poland—Pharmacists’ Opinions. Health Policy 2020, 124, 563–567. [Google Scholar] [CrossRef] [PubMed]
- Mercadante, A.R.; Law, A.V. Will They, or Won’t They? Examining Patients’ Vaccine Intention for Flu and COVID-19 Using the Health Belief Model. Res. Soc. Adm. Pharm. 2021, 17, 1596–1605. [Google Scholar] [CrossRef] [PubMed]
- Kelland, K. Exclusive: International COVID-19 Vaccine Poll Shows Higher Mistrust of Russia, China Shots; Reuters: London, UK, 2021. [Google Scholar]
- Hosa, J.; Tcherneva, V. Vessela Pandemic Trends: Serbia Looks East, Ukraine Looks West—European Council on Foreign Relations; ECFR: Berlin, Germany, 2021. [Google Scholar]
- Song, H.; Omori, K.; Kim, J.; Tenzek, K.E.; Hawkins, J.M.; Lin, W.-Y.; Kim, Y.-C.; Jung, J.-Y. Trusting Social Media as a Source of Health Information: Online Surveys Comparing the United States, Korea, and Hong Kong. J. Med. Internet Res. 2016, 18, e4193. [Google Scholar] [CrossRef] [PubMed]
- Coloma, P.M.; Becker, B.; Sturkenboom, M.C.J.M.; van Mulligen, E.M.; Kors, J.A. Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies. Drug Saf. 2015, 38, 921–930. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Betsch, C.; Renkewitz, F.; Betsch, T.; Ulshöfer, C. The Influence of Vaccine-Critical Websites on Perceiving Vaccination Risks. J. Health Psychol. 2010, 15, 446–455. [Google Scholar] [CrossRef] [PubMed]
- Ferdinand, K.C.; Nedunchezhian, S.; Reddy, T.K. The COVID-19 and Influenza “Twindemic”: Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans. J. Natl. Med. Assoc. 2020, 112, 681–687. [Google Scholar] [CrossRef] [PubMed]
- Infographic: The Countries Where Vaccination Is Mandatory. Available online: https://www.statista.com/chart/25326/obligatory-vaccination-against-covid-19/ (accessed on 17 September 2021).
- Dzehtsiarou, K. Compulsory Vaccination: What Does Human Rights Law Say? Available online: http://theconversation.com/compulsory-vaccination-what-does-human-rights-law-say-167735 (accessed on 17 September 2021).
- Solís Arce, J.S.; Warren, S.S.; Meriggi, N.F.; Scacco, A.; McMurry, N.; Voors, M.; Syunyaev, G.; Malik, A.A.; Aboutajdine, S.; Adeojo, O.; et al. COVID-19 Vaccine Acceptance and Hesitancy in Low- and Middle-Income Countries. Nat. Med. 2021, 27, 1385–1394. [Google Scholar] [CrossRef] [PubMed]
Question | Question Content | Possible Answers |
---|---|---|
1 # | Have you ever been vaccinated against influenza? | Yes, annually/Yes, occasionally/No |
2 # | Willingness to be vaccinated against influenza in the season 2020/21 | Yes, and I was vaccinated/Yes, but the vaccine was not available/No |
3 # | If your answer was “affirmative” in the previous question, please indicate why? If the answer was “no” please skip this question and go to question 4. | Multiple choice possibility |
4 # | If you answered “no” in question 2 please indicate why? | Multiple choice possibility |
5 # | If you answered “no” in question 2 please indicate what could change your decision? | Multiple choice possibility |
6 # | Do you think that vaccination against influenza should be obligatory? | Agree/Agree but only for those from the risk group/Disagree |
7 ^ | Have you been infected with the coronavirus (infection confirmed by the PCR test) | Yes, and the course of illness was severe/Yes, and the course of illness was mild/Yes, and the course of illness was asymptomatic/No |
8 ^ | Would you be vaccinated against COVID-19? | - Yes/no |
9 ^ | If you answered “disagree” in the previous question, please indicate why? If the answer was affirmative, please skip this question and go to question 5. | Multiple choice possibility |
10 ^ | If you answered “disagree” in the previous question, please indicate what could change your decision? | Multiple choice possibility |
11 ^ | Do you think that vaccination against COVID-19 should be obligatory? | Agree/Agree but only for those from the risk group/Disagree |
Country | Age Range * | Sex | Place of Residence | Level of Education | Work/Education Related to Healthcare ^ | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 # | 2 # | 3 # | Female | Male | 1 # | 2 # | 3 # | 1 # | 2 # | 3 # | Yes | |
Poland | 18–26 (65.5%) | 36–45 (9.9%) | 27–35 (9.8%) | 73.8% | 26.2% | City > 500 thousands of residents (35%) | City with 100–500 thiousands of residents (20.9%) | City < 50 thousands of residents (19.6%) | Student (47.5%) | Higher (38.2%) | Secondary (10.31%) | 61.2% |
Ukraine | 27–35 (32.5%) | 36–45 (29.7%) | 46–60 (16.8%) | 82.3% | 17.7% | City > 500 thousands of residents (49.5%) | City with 100–500 thiousands of residents (19.7%) | City < 50 thousands of residents (14.4%) | Higher (83%) | Student (7%) | Secondary (6.1%) | 38.4% |
Lithuania | 18–26 (39.44%) | 36–45 (17.37%) | 27–35 (14.55%) | 72.77% | 27.23% | City with 100–500 thiousands of residents (41.31%) | City < 50 thousands of residents (19.72%) | City with 50–100 thiousands of residents (14.08%) | Higher (60.56%) | Student (23.0%) | Secondary (7.98%) | 53.5% |
Country | Have You Ever Been Vaccinated against Influenza? # | Willingness to Be Vaccinated against Influenza in the Season 2020/21 # | ||||
---|---|---|---|---|---|---|
Yes, Annually | Yes, Occasionally | No | Yes, and I Was Vaccinated | Yes, but the Vaccine Was Not Available | No | |
Poland | 10.7% | 28.3% | 61% | 16.4% | 19.6% | 64% |
Ukraine | 10.7% | 16.4% | 72.9% | 14.8% | 12.5% | 72.7% |
Lithuania | 10.33% | 20.66% | 69.01% | 17.84% | 16.9% | 65.26% |
Country | Question 3 | Question 4 | Question 5 | Question 9 | Question 10 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 # | 2 # | 3 # | 1 # | 2 # | 3 # | 1 # | 2 # | 3 # | 1 # | 2 # | 3 # | 1 # | 2 # | 3 # | |
Poland | “I feel safe being vaccinated against influenza” (80.69%) | “employers cover the costs of vaccination” (13.3%) | “I know that it is important” (11.4%) | “I am not in a risk group” (48.9%) | “I am afraid of side effects” (25.3%) | “I have never got influenza (15.1%) | “Being in a risk group” (46.25%) | “Worsening of the pandemic course” (37.8%) | “Better access to vaccines” (24.2%) | “I am afraid of COVID-19 vaccines safeness” (76.4%) | “I am not in a risk group” (28.6%) | “I am afraid of vaccines costs” (23.4%) | “If it will be necessary” (59.1% | “Getting knowledge about the process of production and vaccine composition” (25.8%) | “Longer market availability” (13.4%) |
Ukraine | “I feel safe being vaccinated against influenza” (59.3%) | “I am in a risk group” (19.1%) | “in the past, my relatives or I was seriously ill due to influenza” (10.9%) | “I am anti-vaccines” (41%) | “I am afraid of side effects” (32%) | “I am not in a risk group” (12.5%) | “Nothing can change my decision” (61.9%) | “Being in a risk group” (9.7%) | “Worsening of the pandemic course” (7.8%) | “I am afraid of COVID-19 vaccines safeness” (34.3%) | “I do not believe in vaccines” (32.4%) | “I am not in a risk group” (13.9%) | “Nothing can change my decision” (63.2%) | “Longer market availability” (18.1%) | “Worsening of the pandemic course” (4.7%) |
Lithuania | “I feel safe being vaccinated against influenza” (26.29%) | “employers cover the costs of vaccination” (5.63%) | “I am in a risk group” (3.75%) | “I am not in a risk group” (25.35%) | “I am not interested in vaccination” (25.35%) | Other (answer not specified) (10.33%) | “Being in a risk group” (26.29%) | “Nothing can change my decision” (21.13%) | “Serious influenza complications in my family” (19.72%) | “I am afraid of COVID-19 vaccines safeness” (50%) | “I do not believe in vaccines” (25.0%) | “I am not in a risk group” (25.0%) | “Nothing can change my decision” (55.36%) | “Longer market availability” (48.21%) | “Severe course and complications after COVID-19 in my family” (23.21%) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zaprutko, T.; Kremin, Y.; Michalak, M.; Bernatoniene, J.; Zaprutko, L.; Hudz, N.; Stolecka, A.; Cynar, J.; Niewczas, K.; Sprawka, J.; et al. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine. Int. J. Environ. Res. Public Health 2022, 19, 2042. https://doi.org/10.3390/ijerph19042042
Zaprutko T, Kremin Y, Michalak M, Bernatoniene J, Zaprutko L, Hudz N, Stolecka A, Cynar J, Niewczas K, Sprawka J, et al. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine. International Journal of Environmental Research and Public Health. 2022; 19(4):2042. https://doi.org/10.3390/ijerph19042042
Chicago/Turabian StyleZaprutko, Tomasz, Yuliia Kremin, Michał Michalak, Jurga Bernatoniene, Lucjusz Zaprutko, Nataliia Hudz, Aleksandra Stolecka, Julia Cynar, Katarzyna Niewczas, Józefina Sprawka, and et al. 2022. "Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine" International Journal of Environmental Research and Public Health 19, no. 4: 2042. https://doi.org/10.3390/ijerph19042042
APA StyleZaprutko, T., Kremin, Y., Michalak, M., Bernatoniene, J., Zaprutko, L., Hudz, N., Stolecka, A., Cynar, J., Niewczas, K., Sprawka, J., Skorupska, P., Wróbel, J., Ratajczak, P., Kopciuch, D., Paczkowska, A., Kus, K., & Hromovyk, B. (2022). Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine. International Journal of Environmental Research and Public Health, 19(4), 2042. https://doi.org/10.3390/ijerph19042042